Leo Kretzner

4.2k total citations · 3 hit papers
28 papers, 3.6k citations indexed

About

Leo Kretzner is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Leo Kretzner has authored 28 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Neurology. Recurrent topics in Leo Kretzner's work include RNA Research and Splicing (10 papers), RNA modifications and cancer (7 papers) and RNA and protein synthesis mechanisms (6 papers). Leo Kretzner is often cited by papers focused on RNA Research and Splicing (10 papers), RNA modifications and cancer (7 papers) and RNA and protein synthesis mechanisms (6 papers). Leo Kretzner collaborates with scholars based in United States, United Kingdom and South Africa. Leo Kretzner's co-authors include Robert N. Eisenman, Elizabeth M. Blackwood, T. Keith Blackwell, Donald E. Ayer, Harold Weintraub, Michael Rosbash, Bertrand Séraphin, Averil Ma, Frederick W. Alt and Jing Huang and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Leo Kretzner

28 papers receiving 3.5k citations

Hit Papers

Sequence-Specific DNA Binding by the c-Myc Protein 1988 2026 2000 2013 1990 1993 1988 250 500 750

Peers

Leo Kretzner
Frank McCormick United States
Richard Kris United States
N.C. Popescu United States
Elizabeth E. Reczek United States
Jakob Lovén United States
Sing Rong United States
Frank McCormick United States
Leo Kretzner
Citations per year, relative to Leo Kretzner Leo Kretzner (= 1×) peers Frank McCormick

Countries citing papers authored by Leo Kretzner

Since Specialization
Citations

This map shows the geographic impact of Leo Kretzner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Kretzner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Kretzner more than expected).

Fields of papers citing papers by Leo Kretzner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo Kretzner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Kretzner. The network helps show where Leo Kretzner may publish in the future.

Co-authorship network of co-authors of Leo Kretzner

This figure shows the co-authorship network connecting the top 25 collaborators of Leo Kretzner. A scholar is included among the top collaborators of Leo Kretzner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo Kretzner. Leo Kretzner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gaur, Shikha, Yafan Wang, Leo Kretzner, et al.. (2014). Pharmacodynamic and pharmacogenomic study of the nanoparticle conjugate of camptothecin CRLX101 for the treatment of cancer. Nanomedicine Nanotechnology Biology and Medicine. 10(7). 1477–1486. 53 indexed citations
2.
Kretzner, Leo, Anna Scuto, Claudia Kowolik, et al.. (2011). Combining Histone Deacetylase Inhibitor Vorinostat with Aurora Kinase Inhibitors Enhances Lymphoma Cell Killing with Repression of c-Myc, hTERT, and microRNA Levels. Cancer Research. 71(11). 3912–3920. 89 indexed citations
3.
Scuto, A, Pavel Krejčı́, Leslie Popplewell, et al.. (2010). The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival. Leukemia. 25(3). 538–550. 101 indexed citations
4.
Kretzner, Leo, et al.. (2010). Human non-CG methylation. Epigenetics. 5(7). 569–572. 19 indexed citations
5.
Scuto, Anna, Mark Kirschbaum, Claudia Kowolik, et al.. (2008). The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph− acute lymphoblastic leukemia cells. Blood. 111(10). 5093–5100. 119 indexed citations
6.
Kretzner, Leo, Anna Scuto, Ágnes Juhász, et al.. (2006). Combination of the Histone Deacetylase Inhibitor Vorinostat and Dasatinib Increases Apoptosis in Bcr-abl+ Cells and Reverses Changes Associated with CML Progression.. Blood. 108(11). 2165–2165. 1 indexed citations
7.
8.
Crocitto, Laura E., Leo Kretzner, Sarah L. Blair, et al.. (2004). Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results. Urology. 64(4). 821–825. 48 indexed citations
9.
Li, Jun & Leo Kretzner. (2003). The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc. Molecular and Cellular Biochemistry. 250(1-2). 91–105. 70 indexed citations
10.
Clark, Jarrod, et al.. (2003). Use of microfluidics chips for the detection of human telomerase RNA. Analytical Biochemistry. 313(2). 331–334. 12 indexed citations
11.
Klenova, Elena, Sara R. Fagerlie, Galina N. Filippova, et al.. (1998). Characterization of the Chicken CTCF Genomic Locus, and Initial Study of the Cell Cycle-regulated Promoter of the Gene. Journal of Biological Chemistry. 273(41). 26571–26579. 22 indexed citations
12.
Blackwood, Elizabeth M., T G Lugo, Leo Kretzner, et al.. (1994). Functional analysis of the AUG- and CUG-initiated forms of the c-Myc protein.. Molecular Biology of the Cell. 5(5). 597–609. 35 indexed citations
13.
Ayer, Donald E., Leo Kretzner, & Robert N. Eisenman. (1993). Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell. 72(2). 211–222. 609 indexed citations breakdown →
14.
Blackwell, T. Keith, Jing Huang, Averil Ma, et al.. (1993). Binding of Myc Proteins to Canonical and Noncanonical DNA Sequences. Molecular and Cellular Biology. 13(9). 5216–5224. 118 indexed citations
15.
Kretzner, Leo, Elizabeth M. Blackwood, & Robert N. Eisenman. (1992). Transcriptional Activities of the Myc and Max Proteins in Mammalian Cells. Current topics in microbiology and immunology. 182. 435–443. 35 indexed citations
16.
Blackwood, Elizabeth M., Leo Kretzner, & Robert N. Eisenman. (1992). Myc and Max function as a nucleoprotein complex. Current Opinion in Genetics & Development. 2(2). 227–235. 125 indexed citations
17.
Blackwood, Elizabeth M., Leo Kretzner, & Robert N. Eisenman. (1992). Myc and Max function as a nucleoprotein complex. Current Biology. 2(4). 206–206. 6 indexed citations
18.
Kretzner, Leo, Elizabeth M. Blackwood, & Robert N. Eisenman. (1992). Myc and Max proteins possess distinct transcriptional activities. Nature. 359(6394). 426–429. 407 indexed citations
19.
Blackwood, Elizabeth M., Bernhard Lüscher, Leo Kretzner, & R N Eisenman. (1991). The Myc:Max Protein Complex and Cell Growth Regulation. Cold Spring Harbor Symposia on Quantitative Biology. 56(0). 109–117. 35 indexed citations
20.
Kretzner, Leo, Alain Krol, & Michael Rosbash. (1990). Saccharomyces cerevisiae U1 small nuclear RNA secondary structure contains both universal and yeast-specific domains.. Proceedings of the National Academy of Sciences. 87(2). 851–855. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026